REVOLUTION MEDICINES INC (RVMD) Stock Overview
NASDAQ:RVMD - US76155X1000 - Common Stock
RVMD Key Statistics, Chart & Performance
The current stock price of RVMD is 38.95 USD. In the past month the price increased by 6.22%. In the past year, price decreased by -6.91%.
RVMD Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 20.11 | 376.28B | ||
| AMGN | AMGEN INC | 12.84 | 150.79B | ||
| GILD | GILEAD SCIENCES INC | 14.57 | 139.93B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 23.43 | 101.77B | ||
| REGN | REGENERON PHARMACEUTICALS | 12.43 | 60.12B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 59.45B | ||
| ARGX | ARGENX SE - ADR | 79.14 | 44.90B | ||
| ONC | BEONE MEDICINES LTD-ADR | 6.42 | 37.89B | ||
| INSM | INSMED INC | N/A | 30.13B | ||
| BNTX | BIONTECH SE-ADR | N/A | 24.88B | ||
| NTRA | NATERA INC | N/A | 22.86B | ||
| BIIB | BIOGEN INC | 8.74 | 20.52B |
Related stock screener links
About RVMD
Company Profile
Revolution Medicines, Inc. is a clinical-stage precision oncology company, which engages in developing novel targeted therapies. The company is headquartered in Redwood City, California and currently employs 700 full-time employees. The company went IPO on 2020-02-13. The Company’s research and development pipeline comprises RAS(ON) inhibitors that bind directly to RAS variants, which it refers to as RAS(ON) Inhibitors, and RAS companion inhibitors that target key nodes in the RAS pathway or associated pathways, which it refers to as RAS Companion Inhibitors. Its RAS(ON) Inhibitors are designed to be used as monotherapy, in combination with other RAS(ON) Inhibitors and/or in combination with RAS Companion Inhibitors or other therapeutic agents. The company’s RAS(ON) inhibitors are daraxonrasib (RMC-6236), an RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), an RAS(ON) G12C-selective inhibitor; and zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor, are in clinical development. The Company’s pipeline also focuses on RAS(ON) mutant-selective inhibitors, including RMC-0708 (Q61H) and RMC-8839 (G13C).
Company Info
REVOLUTION MEDICINES INC
700 Saginaw Dr
Redwood City CALIFORNIA 94063 US
CEO: Mark A. Goldsmith
Employees: 700
Phone: 14157663638
REVOLUTION MEDICINES INC / RVMD FAQ
What is the stock price of REVOLUTION MEDICINES INC today?
The current stock price of RVMD is 38.95 USD. The price decreased by -2.06% in the last trading session.
What is the ticker symbol for REVOLUTION MEDICINES INC stock?
The exchange symbol of REVOLUTION MEDICINES INC is RVMD and it is listed on the Nasdaq exchange.
On which exchange is RVMD stock listed?
RVMD stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for REVOLUTION MEDICINES INC stock?
19 analysts have analysed RVMD and the average price target is 73.83 USD. This implies a price increase of 89.56% is expected in the next year compared to the current price of 38.95. Check the REVOLUTION MEDICINES INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is REVOLUTION MEDICINES INC worth?
REVOLUTION MEDICINES INC (RVMD) has a market capitalization of 7.28B USD. This makes RVMD a Mid Cap stock.
How many employees does REVOLUTION MEDICINES INC have?
REVOLUTION MEDICINES INC (RVMD) currently has 700 employees.
What are the support and resistance levels for REVOLUTION MEDICINES INC (RVMD) stock?
REVOLUTION MEDICINES INC (RVMD) has a support level at 37.9 and a resistance level at 40.24. Check the full technical report for a detailed analysis of RVMD support and resistance levels.
Is REVOLUTION MEDICINES INC (RVMD) expected to grow?
The Revenue of REVOLUTION MEDICINES INC (RVMD) is expected to grow by 2012.42% in the next year. Check the estimates tab for more information on the RVMD EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy REVOLUTION MEDICINES INC (RVMD) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of RVMD, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of RVMD, evaluating the profitability, health, valuation and growth aspects
- REVOLUTION MEDICINES INC (RVMD) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- REVOLUTION MEDICINES INC (RVMD) Sales and EPS estimates to see what analysts future expectations are.
- REVOLUTION MEDICINES INC (RVMD) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- REVOLUTION MEDICINES INC (RVMD) Insider and Institutional Ownership to learn about the owners and their transactions.
- REVOLUTION MEDICINES INC (RVMD) Stock Chart to make your own analysis
- REVOLUTION MEDICINES INC (RVMD) Latest news and press-releases to stay up to date.
Does REVOLUTION MEDICINES INC (RVMD) stock pay dividends?
RVMD does not pay a dividend.
When does REVOLUTION MEDICINES INC (RVMD) report earnings?
REVOLUTION MEDICINES INC (RVMD) will report earnings on 2025-11-04, after the market close.
What is the Price/Earnings (PE) ratio of REVOLUTION MEDICINES INC (RVMD)?
REVOLUTION MEDICINES INC (RVMD) does not have a PE ratio as the earnings reported over the last twelve months were negative (-4.5).
What is the Short Interest ratio of REVOLUTION MEDICINES INC (RVMD) stock?
The outstanding short interest for REVOLUTION MEDICINES INC (RVMD) is 8.33% of its float. Check the ownership tab for more information on the RVMD short interest.
RVMD Technical Analysis
ChartMill assigns a technical rating of 4 / 10 to RVMD. When comparing the yearly performance of all stocks, RVMD is a bad performer in the overall market: 80.31% of all stocks are doing better.
RVMD Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to RVMD. RVMD has a great financial health rating, but its profitability evaluates not so good.
RVMD Financial Highlights
Over the last trailing twelve months RVMD reported a non-GAAP Earnings per Share(EPS) of -4.5. The EPS decreased by -23.52% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -23.46% | ||
| ROE | -26.49% | ||
| Debt/Equity | 0 |
RVMD Forecast & Estimates
19 analysts have analysed RVMD and the average price target is 73.83 USD. This implies a price increase of 89.56% is expected in the next year compared to the current price of 38.95.
For the next year, analysts expect an EPS growth of -49.65% and a revenue growth 2012.42% for RVMD